Learn More
Medchemexpress LLC Selonsertib | 1448428-04-3 | 99.1% | 445.49 | 200 MG

Supplier: Medchemexpress LLC HY18938200MG
Selonsertib (GS-4997) is an orally bioavailable, selective apoptosis signal-regulating kinase 1 (ASK1) inhibitor with a pIC50 of 8.3. It has been evaluated as an experimental treatment for diabetic nephropathy and kidney fibrosis. It is a highly selective and potent once-daily oral ASK1 inhibitor that competes with ATP in the ASK1 catalytic kinase domain.
- Orally bioavailable.
- Selective apoptosis signal-regulating kinase 1 (ASK1) inhibitor.
- pIC50 of 8.3 for ASK1.
- Competes with ATP in the ASK1 catalytic kinase domain.
- Highly selective and potent once-daily oral ASK1 inhibitor.
- Evaluated as an experimental treatment for diabetic nephropathy and kidney fibrosis.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.